| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.001 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |